Express News | Allarity Therapeutics Inc - Two Patients Exceed 14 Months on Treatment in Phase 2 Trial

ReutersNov 18 08:00 ET

Express News | Allarity Therapeutics Inc - Maintains Cash Balance of $18.5 Million

ReutersNov 18 08:00 ET

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

GlobeNewswireNov 18 08:00 ET

Allarity Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 14 16:25 ET · Announcements

Express News | Allarity Therapeutics Q3 EPS $(7.71) Beats $(8.40) Estimate

BenzingaNov 14 08:28 ET

Allarity Therapeutics | 8-K: Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights

SECNov 14 08:21 ET